Tet2 -Clonal Hematopoiesis Promotes Whereas Dnmt3a -CH Inhibits Breast Cancer Progression During Aging
Preprint
Abstract
Clonal hematopoiesis of indeterminate potential (CHIP) driven by somatic mutations in blood cells increases with age and is associated with adverse outcomes in cancer patients. How CHIP mutations influence solid tumor progression remains unclear. Using inducible murine models of Dnmt3a -or Tet2 -mutant CHIP combined with orthotopic syngeneic breast cancer models, we demonstrate that upon aging Dnmt3a -mutant CHIP prevents whereas Tet2 -mutant CHIP drives breast cancer progression. Dnmt3a -mutant immune infiltrates established interferon-mediated MHCII high tumor-associated macrophages (TAMs) that supported cytotoxic CD8+ T cell-mediated tumor rejection. In contrast, Tet2 -mutant TAMs exhibited an inflammatory, immunosuppressive phenotype characterized by increased IL-1 and CXCL2 production, reduced MHCII expression, and impaired T cell recruitment and activation. Therapeutic blockade of IL-1R1 or CXCR2 reduced tumor progression in aged Tet2 -mutant CHIP mice and partially restored anti-tumor immunity. These findings establish that the effects of CHIP on cancer are mutation- and age-dependent and identify IL-1/CXCL2-driven inflammation as a therapeutic vulnerability of tumor-promoting Tet2 -mutant CHIP.This publication has 57 references indexed in Scilit:
- Clonal Hematopoiesis and Risk of Trastuzumab-Related Cardiotoxic EffectsJAMA Oncology, 2026
- Impact of Clonal Hematopoiesis of Indeterminate Potential on Treatment Response and Tumor Microenvironment in Breast Cancer Patients Undergoing Neoadjuvant ChemotherapyJournal of Mammary Gland Biology and Neoplasia, 2026
- Macelignan targets SLC7A11 to induce ferroptosis and modulate macrophage polarization via STAT6/PPAR-γ/KLF4 signalingBioorganic Chemistry, 2025
- TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumorsCancer Cell, 2025
- Targeting CLEC4E in immunosuppressive tumour‐associated macrophages via BET inhibitionClinical and Translational Medicine, 2025
- Clonal Hematopoiesis: Impact on Health and DiseaseHematological Oncology, 2025
- Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunityCancer Cell, 2024
- Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate CancerCell Reports, 2019
- CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2Cancer Letters, 2018
- CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal AdenocarcinomaCancer Cell, 2016